Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-18

FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for methamphetamine hydrochloride (Hikma Pharmaceuticals USA Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHAMPHETAMINE HYDROCHLORIDE (Methamphetamine hydrochloride)

Snippet

SUPPL AP for METHAMPHETAMINE HYDROCHLORIDE (METHAMPHETAMINE HYDROCHLORIDE)